Manager × security

Penn Capital Management Company, LLC MIRM holdings history

Who else holds this security? →

MIRUM PHARMACEUTICALS INC · CUSIP 604749101 · CIK 1158202

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Penn Capital Management Company, LLC reported 298.91K MIRM (shares), valued at $35.06M, or 2.22% of its reported non-derivative portfolio. Filed 2026-07-30.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.22%
Shares
298.91K
298,914
Reported value
$35.06M
USD

Shares increased 16.41%; reported value increased 47.45%, and weight changed +0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20262.22%298,914SEC filing ↗Filed Jul 30, 2026
Q1 20261.84%256,767SEC filing ↗Filed May 7, 2026
Q4 20251.78%281,918SEC filing ↗Filed Feb 9, 2026
Q3 20251.74%307,991SEC filing ↗Filed Nov 24, 2025
Q2 20251.51%342,256SEC filing ↗Filed Aug 14, 2025
Q1 20251.64%373,519SEC filing ↗Filed May 14, 2025
Q4 20241.13%278,427SEC filing ↗Filed Feb 14, 2025
Q3 20241.11%309,244SEC filing ↗Filed Nov 14, 2024
Q2 20240.78%241,151SEC filing ↗Filed Aug 13, 2024
Q1 20240.55%245,696SEC filing ↗Filed May 15, 2024
Q4 20230.67%245,728SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.67%245,728$7.26MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20240.55%245,696$6.18MShares decreased 0.01%; reported value decreased 14.92%, and weight changed -0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20240.78%241,151$8.26MShares decreased 1.85%; reported value increased 33.59%, and weight changed +0.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20241.11%309,244$12.09MShares increased 28.24%; reported value increased 46.45%, and weight changed +0.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20241.13%278,427$11.51MShares decreased 9.97%; reported value decreased 4.78%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.64%373,519$16.87MShares increased 34.15%; reported value increased 46.53%, and weight changed +0.51 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20251.51%342,256$17.46MShares decreased 8.37%; reported value increased 3.51%, and weight changed -0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20251.74%307,991$22.63MShares decreased 10.01%; reported value increased 29.59%, and weight changed +0.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 24, 2025
Q4 20251.78%281,918$22.32MShares decreased 8.47%; reported value decreased 1.37%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 9, 2026
Q1 20261.84%256,767$23.78MShares decreased 8.92%; reported value increased 6.51%, and weight changed +0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 7, 2026
Q2 20262.22%298,914$35.06MShares increased 16.41%; reported value increased 47.45%, and weight changed +0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 30, 2026
Penn Capital Management Company, LLC · MIRUM PHARMACEUTICALS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1158202","quarter":"2026Q2","cusip":"604749101"}

get_institutional_manager_history
{"cik":"1158202","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.